Evidence map›Paper›PMID 41410704›Full record

ArticleArchives of virology2025

Molecular characterization of a novel macluravirus from Curcuma alismatifolia identified by high-throughput sequencing.

Hanhong Lan, Fangluan Gao, Huiwen Yu, Luanmei Lu

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hanhong LanKey Laboratory of Landscape Plants with Fujian and Taiwan Characteristics of Fujian Colleges and Universities, School of Biological Sciences and Biotechnology, Minnan Normal University, Zhangzhou, Fujian, 363000, People's Republic of China. lanhanh@163.com.ORCID http://orcid.org/0000-0002-3990-5021
Fangluan GaoFujian Key Laboratory of Plant Virology, Institute of Plant Virology, Fujian Agriculture and Forestry University, Fuzhou, 350002, People's Republic of China.
Huiwen YuKey Laboratory of Landscape Plants with Fujian and Taiwan Characteristics of Fujian Colleges and Universities, School of Biological Sciences and Biotechnology, Minnan Normal University, Zhangzhou, Fujian, 363000, People's Republic of China.
Luanmei LuKey Laboratory of Landscape Plants with Fujian and Taiwan Characteristics of Fujian Colleges and Universities, School of Biological Sciences and Biotechnology, Minnan Normal University, Zhangzhou, Fujian, 363000, People's Republic of China. 358070295@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complete sequence of Curcuma alismatifolia bract virus (CurABV) from the city of Zhangzhou in Fujian Province, China, was determined by high-throughput sequencing. The viral genome consists of 8273 nucleotides (nt) and encodes a large polyprotein of 2634 amino acids (aa). In silico analysis predicted that this polyprotein is cleaved by two viral proteases into nine mature proteins. Sequence comparisons showed that CurABV shares 48.60-74.40% nt and 48.71-71.49% aa sequence identity with other macluraviruses in the coat protein (CP) gene. Phylogenetic analysis showed that CurABV clustered with representative members of the genus Macluravirus. These data suggest that CurABV is a new member of the genus Macluravirus. To our knowledge, this is the first report of the complete genome sequence of a macluravirus infecting C. alismatifolia.

Indexed as

CurcumaGenome, ViralPlant DiseasesAmino Acid SequenceChinaHigh-Throughput Nucleotide SequencingPhylogenyRNA, ViralViral ProteinsRNA, ViralViral Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.